SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-06-034669
Filing Date
2006-02-17
Accepted
2006-02-17 16:05:28
Documents
4
Period of Report
2006-02-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 18366
2 FORM OF SUBSCRIPTION AGREEMENT dex105.htm EX-10.5 239548
3 PRESS RELEASE dex991.htm EX-99.1 10466
4 GRAPHIC g74167image1.jpg GRAPHIC 29377
  Complete submission text file 0001193125-06-034669.txt   310667
Mailing Address 13950 BALLANTYNE CORPORATE PLACE UNIT 325 CHARLOTTE NC 28277
Business Address 13950 BALLANTYNE CORPORATE PLACE UNIT 325 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51462 | Film No.: 06629301
SIC: 2836 Biological Products, (No Diagnostic Substances)